Results 231 to 240 of about 6,020,192 (375)

Is DEXI a Multiple Sclerosis Susceptibility Gene? [PDF]

Int J Mol Sci
Eriksson AM, Emini N, Harbo HF, Berge T.
europepmc   +1 more source

Validating the Accuracy of Parkinson's Disease Clinical Diagnosis: A UK Brain Bank Case–Control Study

Annals of Neurology, EarlyView.
Objective Despite diagnostic criteria refinements, Parkinson's disease (PD) clinical diagnosis still suffers from a not satisfying accuracy, with the post‐mortem examination as the gold standard for diagnosis. Seminal clinicopathological series highlighted that a relevant number of patients alive‐diagnosed with idiopathic PD have an alternative post ...
Lazzaro di Biase, Pasquale Maria Pecoraro, Vincenzo Di Lazzaro   +2 more
wiley   +1 more source

Microglial/macrophage activation in the cerebrospinal fluid of neuromyelitis optica spectrum disorders

Brain and Behavior, Volume 12, Issue 12, December 2022., 2022
Abstract Aim The aims of this pilot study were to investigate the levels of biomarkers of microglial/macrophage activation—YKL‐40, sCD163, and sCD14—in patients with neuromyelitis optica spectrum disorder (NMOSD) and determine the possible associations between these biomarkers and Expanded Disability Status Scale (EDSS) scores.
Jinghong Li, Yan He, Honghao Wang, Jinyu Chen   +3 more
wiley   +1 more source

Frequency and Early Predictors of Cognitive Deterioration in Amyotrophic Lateral Sclerosis: A Longitudinal Population‐Based Study

Annals of Neurology, EarlyView.
Objective The objective is to evaluate cognitive and behavioral progression and identify early predictors of these changes in a cohort of amyotrophic lateral sclerosis (ALS) patients. Methods A total of 161 ALS patients were tested at diagnosis (T0), and 107 were re‐tested after 1 year (T1) using cognitive/behavioral tests. All patients underwent whole‐
Barbara Iazzolino, Francesca Palumbo, Cristina Moglia, Umberto Manera, Maurizio Grassano, Enrico Matteoni, Sara Cabras, Maura Brunetti, Rosario Vasta, Marco Pagani, Gabriele Mora, Antonio Canosa, Andrea Calvo, Adriano Chiò   +13 more
wiley   +1 more source

Processing efficiency in pediatric cancer survivors: A review and operationalization for outcomes research and clinical utility

Brain and Behavior, Volume 12, Issue 12, December 2022., 2022
Abstract Objective Childhood cancer and cancer‐related treatments disrupt brain development and maturation, placing survivors at risk for cognitive late effects. Given that assessment tools vary widely across researchers and clinicians, it has been daunting to identify distinct patterns in outcomes across diverse cancer types and to implement ...
Julie A. Trapani, Donna L. Murdaugh
wiley   +1 more source

Macular inner retinal layers in multiple sclerosis. [PDF]

Front Neurol
Zahavi O, Nilsson M, Manouchehrinia A, Brautaset R, Kockum I, Venkataraman AP, Dominguez-Vicent A.   +6 more
europepmc   +1 more source

Cyanide metabolism and vitamin B12 in multiple sclerosis. [PDF]

, 1965
D. M. Matthews, John Wilson, K J Zilkha
openalex   +1 more source

Multiple sclerosis following SARS-CoV-2 infection

Multiple Sclerosis and Related Disorders, 2020
M. Palao, E. Fernández-Diaz, J. Gracia-Gil, C. M. Romero-Sánchez, I. Díaz-Maroto, T. Segura   +5 more
semanticscholar   +1 more source

Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study

Annals of Neurology, EarlyView.
Objective The neurodegenerative processes driving the build‐up of disability in progressive multiple sclerosis (P‐MS) have not been fully elucidated. Recent data link cellular senescence (CS) to neurodegeneration. We investigated for evidence of CS in P‐MS and sought to determine its pattern.
Dimitrios Papadopoulos, Roberta Magliozzi, Sara Bandiera, Ilaria Cimignolo, Elena Barusolo, Lesley Probert, Vassilis Gorgoulis, Richard Reynolds, Richard Nicholas   +8 more
wiley   +1 more source

Editorial: Neuroplasticity in multiple sclerosis. [PDF]

Front Neurol
Yalachkov Y, Karimi-Abdolrezaee S, Tavazzi E.   +2 more
europepmc   +1 more source